Searched for
METOPROLOL TARTRATE TABLETS
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Pharma stocks: Moving from ‘What if’ to ‘Maybe not’. 8 pharma stocks, 3 with upside potential above 22%; others not so high, but…There are two ways to look at the hope which the street is reflecting when it comes to a possible India-US tariff deal. One, it will bring ...
- Pharma sector: Reasons to look at it beyond the tariff exemption. 7 pharma stocks with an upside potential of up to 43%Along with semiconductors, electronics and IT, pharma is another sector exempt from the Trump tariffs. Still, as the broader indices declin...
- They fall, you catch. One might be a winner in the long term: 8 pharma stocks with upside potential of over 35%Given that the headlines are dominated by what is happening at the border, the street may be forgiven for not noting developments that matt...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 26%The Indian market, in correction mode for five months, is not a standalone underperformer. A part of the correction does and will continue ...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of more than 33% in 1 yearBack in September 2024, who would have thought that bulls would vanish from the street in just six months, and bears would rule? But market...
- These large- and mid-cap stocks can give more than 30% return in 1 year, according to analystsAround this time last year, both policymakers and regulators were worrying about the froth building up in the mid-cap space. A slew of meas...
- Necessary pill for portfolio during volatility and Trump tariff wars: 8 pharma stocks with an upside potential of up to 48%Let’s accept the fact that we are likely to be dealing with volatility for the next four years. Both in the real world and in the global an...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of more than 26%When bears go on a rampage, they don’t discriminate. So, on Monday, no matter what sector, what market cap, everything was in the red. But ...
- A Trump tariff tantrum-proof sector? 8 stocks from pharma sector, where Democrats and Republicans are in agreement, with an upside potential of up to 34% in 1 yearWhen Donald Trump is back in the saddle, one thing is certain: Tariff wars. Yes, China will be the biggest target. But for all those who th...
- Alpha generators in the long term: 9 mid and small cap stocks from pharma and healthcare sector with an upside potential of up to 29%While some make it to the headlines, some don't. Two sectors, healthcare and pharma have been witnessing more mergers and acquisitions than...
- These healthcare and pharma stocks may deliver more than 20% in one yearCheck out Stock Reports Plus, powered by Refinitiv, for price targets of over 4,000 listed stocks along with detailed company analysis focu...
- For all market conditions: 5 largecap stocks from different sectors with upside potential of up to 33%The US interest rates and yields are one of the most important drivers of liquidity in global markets. That is the reason at the first hint...
- Nifty healthcare index stocks; Staying bullish on select pharma and hospitalsWhile they clubbed together, the operating matrix of a pharma company making drugs and hospital and a diagnostic company are very different...
- Nifty healthcare index stocks analysts suggest buying have potential upside of more than 19%Except for a pocket in which demand for covid drugs led to sharp surge in pharma stocks, the pharma sector had been under pressure for a lo...
- Drug makers Glenmark, Aurobindo recall products in USGlenmark Pharmaceuticals Inc, USA is recalling Fulvestrant injection, Naproxen Sodium Tablets, Chlorzoxazone tablets and Arformoterol Tartr...
- Wockhardt shares climb 2% after USFDA makes nil observationIn a regulatory filing, the company said no observations were made after the US drug regulator inspected its Bioequivalence centre.
- Wockhardt recalls over 50 lakh bottles of various drugs in USAs per the information available on the USFDA, Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
- Glenmark recalls 2,904 bottles of Rantidine tablets in US marketGlenmark Generics Inc, the US-based unit of the company, is recalling 2,904 bottles due to the presence of a foreign material in one of the...
Load More
